ziprazidone

DRUG2 trials

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Centre for Addiction and Mental Health

Conditions

Schizoaffective DisorderSchizophrenia

Phase 4

12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients

TerminatedNCT00159757

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Schizophrenia

Start: 2003-11-30End: 2005-02-28Target: 150Updated: 2021-02-21

Unknown Phase

24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study

CompletedNCT00818298

Centre for Addiction and Mental HealthSchizoaffective Disorder, Schizophrenia

Start: 2009-01-31End: 2011-06-30Updated: 2012-07-09

Related Papers

Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study.

2013-02-179 citations